Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Abstract: Pheochromocytoma is a rare catecholamine secreting neuroendocrine tumor arising from chromaffin cells of adrenal medulla with approximate prevalence of 0.1 to 0.6% in patients suffering from hypertension. Hypertensive control followed by surgical resection remains the primary treatment of choice. Although it is considered a slow growing benign tumor, it rarely leads to recurrence of tumor in the lymph nodes, liver, and lungs. Association of benign pheochromocytoma with familial or de novo Von Hippel-Lindau (VHL) mutations is well reported in literature. Here, we report a case of metastatic pheochromocytoma arising from commonly seen benign VHL mutation.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation ; volume:21 ; number:01 ; year:2022 ; pages:073-075
World Journal of Nuclear Medicine ; 21, Heft 01 (2022), 073-075
- Contributor
-
Vankadari, Kousik
Boddula, Raman
Hegde, Aditya Gajanan
Chinte, Chimutai
- DOI
-
10.1055/s-0042-1746177
- URN
-
urn:nbn:de:101:1-2022100815515678779792
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vankadari, Kousik
- Boddula, Raman
- Hegde, Aditya Gajanan
- Chinte, Chimutai
Other Objects (12)
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
VHL mutation as a cause of three generations familial pheochromocytoma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
![Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
VHL mutation as a cause of three generations familial pheochromocytoma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
VHL mutation as a cause of three generations familial pheochromocytoma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging